Will a Genetic Test Result — Affect Your Insurance in India?

No insurer can compel you to undergo genetic testing or hand over results you do not hold. The more complicated question arises if you already have a result. Proposal forms may ask broadly whether you have any known health condition or elevated hereditary disease risk. If your result is relevant to a question as written, non-disclosure could later affect a claim. Read every question carefully before applying, and if any wording is ambiguous, ask an insurance lawyer rather than guessing.

That depends on what your proposal form asked at the time of application. Indian insurance contract law imposes a duty to disclose facts that are material to the risk. Whether your specific genetic result is material to a specific policy question turns on the exact wording of the form — it does not have a universal yes or no answer. If you are applying for new cover and already hold a positive result, read every health and family history question with that result in mind, and consider speaking to an insurance lawyer before submitting.

IRDAI regulations require health insurers to renew a policy unless there is evidence of fraud or deliberate misrepresentation at the time of the original application. A test you take after your policy is in force is new information your insurer did not have when they underwrote you. Whether it can affect renewal terms depends on your policy wording and what you were asked when you applied. This is an open question in Indian insurance practice, not a settled one, and your policy document is the right starting point.

The two products have different underwriting criteria, and the impact of a genetic result may be assessed differently in each. Life insurance applications in India often ask detailed questions about family history and personal health. Some families choose to get life insurance in place before testing as a practical step. This is not a guaranteed solution — policies include non-disclosure clauses — but it removes the uncertainty that a new positive result might otherwise create in your access to cover. Discuss the timing with your oncologist.

A regulatory framework for genetic data has been under discussion in India for several years, including through the DNA Technology (Use and Application) Regulation Bill. Whether any eventual law will include insurance non-discrimination provisions similar to GINA is not yet decided. We do not yet know what form protection will take or when it will arrive. Until it does, the practical steps available to families — securing cover before testing, reading proposal forms carefully — remain the protections in reach.

For families where hereditary cancer is a known concern, securing adequate life and health insurance before testing is a practical step that oncologists often raise when discussing the decision to test. It removes the uncertainty a positive result could create around future access to cover. Whether it makes sense depends on your current coverage, your family's medical history, and your own priorities. It is not the right answer for everyone, and it is a conversation worth having before you book the test.